Vision & Strategie
- Innovationen der Biorevolution
- Consumer Health Trends
- Trends in der Pharmaindustrie
- Trends in der Landwirtschaft
- Investor News
- Events & Präsentationen
- Nachhaltigkeit & Governance
- Dokumente zum Download
Einladung & Tagesordnung
Cancellation of the convened ordinary general meeting and new convening of the ordinary general meeting on April 28, 2020 as a virtual general meeting.
Against the background of the increasing spread of the new type of coronavirus SARS-CoV-2 and the COVID-19 disease caused by it, as well as the existing official ordinances to protect against health risks associated with the virus, the annual general meeting of the Bayer AG canceled.
At the same time, we hereby convene our ordinary general meeting as a virtual general meeting without the physical presence of shareholders or their proxies on Tuesday, April 28, 2020 at 10:00 am
Presentation of the approved annual financial statements and the approved consolidated financial statements, the combined management report, the report of the Supervisory Board and the proposal of the Management Board for the appropriation of the net profit, each for the 2019 financial year, as well as resolution on the use of the net profit
Discharge of the members of the board
Discharge of the members of the supervisory board
Elections to the supervisory board
Approval of the remuneration system for the members of the Management Board
Resolution on the remuneration of the members of the Supervisory Board
Amendment to the articles of association for the term of office of the members of the Supervisory Board
Election of the auditor and the auditor for a possible review of the half-yearly financial report and interim financial reports
Annual financial statements (including the Executive Board's proposal for the appropriation of the balance sheet profit), consolidated financial statements , combined management report , report of the Supervisory Board , in each case for the 2019 financial year (agenda item 1), and the explanatory report by the Executive Board on the takeover-related information as part of the combined management report for Fiscal year 2019 ,
CVs of Mrs. Ertharin Cousin , Prof. Dr. med. Dr. hc mult. Otmar D. Wiestler and Mr. Horst Baier including further information relevant to the proposed elections to the Supervisory Board (agenda item 4),
Articles of Association of the company (agenda items 6 and 7).
These documents are also accessible during the Annual General Meeting.